DONAPAN Tablet Ref.[51298] Active ingredients: Paracetamol

Source: Marketing Authorisation Holder  Revision Year: 2023  Publisher: Oethmaan Biosims (Pty) Ltd, 207A Sherwood House, Greenacres Office Park, c/o Victory and Rustenberg Roads, Victory Park, Johannesburg, 2195

5.1. Pharmacodynamic properties

Pharmacological classification: A 2.7 Antipyretics or antipyretic and anti-inflammatory analgesics
ATC Code: N02BE01

Paracetamol has analgesic and antipyretic activity.

5.2. Pharmacokinetic properties

Absorption

Paracetamol is readily absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 10-60 minutes after oral doses.

Distribution

Paracetamol is distributed into most body tissues. It crosses the placenta and is present in breast milk.

Biotransformation

Paracetamol is mainly metabolised in the liver, following two major hepatic pathways: glucuronic acid conjugation and sulphuric acid conjugation.

Elimination

The metabolites of paracetamol are mainly excreted in the urine. Less than 5% is excreted as unchanged paracetamol. The elimination half-life of paracetamol varies from about 1-3 hours.

5.3. Preclinical safety data

Conventional studies using the currently accepted standards for the evaluation of toxicity to reproduction and development are not available.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.